Literature DB >> 11133921

Ventricular activation during sympathetic imbalance and its computational reconstruction.

M P Nash1, J M Thornton, C E Sears, A Varghese, M O'Neill, D J Paterson.   

Abstract

We characterized the epicardial activation sequence during a norepinephrine (NE)-induced ventricular arrhythmia in anesthetized pigs and studied factors that modulated it. Subepicardial NE infusion caused the QRS complex to invert within a single beat (n = 35 animals, 101 observations), and the earliest epicardial activation consistently shifted to the randomly located infusion site (n = 14). This preceded right atrial activation, whereas the total ventricular epicardial activation time increased from 20 +/- 4 to 50 +/- 9 ms (P < 0.01). These events were accompanied by a ventricular tachycardia and a drop in left ventricular pressure, which were fully reversed after the infusion was stopped. Epicardial pacing at the infusion site mimicked all electrical and hemodynamic changes induced by NE. The arrhythmia was prevented by propranolol and abolished by cardiac sympathetic or vagal nerve stimulation. Focal automaticity was computationally reconstructed using a two-dimensional sheet of 256 x 256 resistively coupled ventricular cells, where calcium handling was abnormally high in the central region. We conclude that adrenergic stimulation to a small region of the ventricle elicits triggered automaticity and that computational reconstruction implicates calcium overload. Interventions that reduce spatial inhomogeneities of intracellular calcium may prevent this type of arrhythmia.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11133921     DOI: 10.1152/jappl.2001.90.1.287

Source DB:  PubMed          Journal:  J Appl Physiol (1985)        ISSN: 0161-7567


  11 in total

Review 1.  Challenges facing validation of noninvasive electrical imaging of the heart.

Authors:  Martyn P Nash; Andrew J Pullan
Journal:  Ann Noninvasive Electrocardiol       Date:  2005-01       Impact factor: 1.468

Review 2.  Peripheral cardiac sympathetic hyperactivity in cardiovascular disease: role of neuropeptides.

Authors:  Julia Shanks; Neil Herring
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2013-09-04       Impact factor: 3.619

Review 3.  The nervous heart.

Authors:  Crystal M Ripplinger; Sami F Noujaim; Dominik Linz
Journal:  Prog Biophys Mol Biol       Date:  2016-01-11       Impact factor: 3.667

4.  Decreased inward rectifying K+ current and increased ryanodine receptor sensitivity synergistically contribute to sustained focal arrhythmia in the intact rabbit heart.

Authors:  Rachel C Myles; Lianguo Wang; Donald M Bers; Crystal M Ripplinger
Journal:  J Physiol       Date:  2014-10-07       Impact factor: 5.182

Review 5.  Molecular Mechanisms of Sympathetic Remodeling and Arrhythmias.

Authors:  Ryan T Gardner; Crystal M Ripplinger; Rachel C Myles; Beth A Habecker
Journal:  Circ Arrhythm Electrophysiol       Date:  2016-02

Review 6.  Autonomic control of the heart: going beyond the classical neurotransmitters.

Authors:  Neil Herring
Journal:  Exp Physiol       Date:  2014-11-20       Impact factor: 2.969

7.  Protection against ventricular fibrillation via cholinergic receptor stimulation and the generation of nitric oxide.

Authors:  Manish Kalla; Minesh Chotalia; Charles Coughlan; Guoliang Hao; Mark J Crabtree; Jakub Tomek; Gil Bub; David J Paterson; Neil Herring
Journal:  J Physiol       Date:  2016-02-04       Impact factor: 5.182

Review 8.  Cardiac sympatho-vagal balance and ventricular arrhythmia.

Authors:  Manish Kalla; Neil Herring; David J Paterson
Journal:  Auton Neurosci       Date:  2016-08-26       Impact factor: 3.145

Review 9.  Molecular and cellular neurocardiology: development, and cellular and molecular adaptations to heart disease.

Authors:  Beth A Habecker; Mark E Anderson; Susan J Birren; Keiichi Fukuda; Neil Herring; Donald B Hoover; Hideaki Kanazawa; David J Paterson; Crystal M Ripplinger
Journal:  J Physiol       Date:  2016-06-17       Impact factor: 5.182

Review 10.  The Role of Neuropeptide Y in Cardiovascular Health and Disease.

Authors:  Cheryl M J Tan; Peregrine Green; Nidi Tapoulal; Adam J Lewandowski; Paul Leeson; Neil Herring
Journal:  Front Physiol       Date:  2018-09-19       Impact factor: 4.566

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.